ALL vs ARES
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
ALL shows bullish fundamentals based on deterministic rules. Financial strength is weak (F-Score 3/9). Key strengths include strong valuation and growth metrics.
ARES exhibits strong fundamental health with a Piotroski F-Score of 7/9, indicating solid profitability and operational efficiency. However, the stock trades at a significant premium to both Graham's defensive value ($26.55) and intrinsic value ($67.56), currently priced at $155.89, reflecting high growth expectations. While revenue and earnings growth are robust—46.7% and 108.8% YoY respectively—the elevated valuation metrics (P/E of 68.07, P/B of 11.40) and bearish insider activity raise sustainability concerns. The technical trend is bearish, and the dividend payout ratio of 181% signals potential instability in income sustainability.
Compare Another Pair
Related Comparisons
ALL vs ARES: Head-to-Head Comparison
This page compares The Allstate Corporation (ALL) and Ares Management Corporation (ARES) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.